Abbott Laboratories

Health Care Providers / Medical Equipment / Pharmaceuticals
ABT
$ 103 0.29
Share price
$ 181 bn
Market Cap
$ 188 bn
Enterprise Value

Carbon footprint

4.9 Ton
GHG emissions per $ 1 mln investment
0.13x the weighted average for S&P 500
FY2021
How is this calculated?
+3.3%
YOY change in GHG emissions
Weaker than the +5% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-2.9%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -6.6% weighted average for S&P 500
FY2022
How is this calculated?

Abbott Laboratories aims to reduce Scope 1 + 2 by 30% by 2030 from a base year 2018


This target has not been verified as science based according to SBTi
Abbott Laboratories's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Abbott Laboratories's GHG emissions (market-based) (Kt of CO2e)
Abbott Laboratories's Carbon intensity (Tons per 1 USDm)

Abbott Laboratories's carbon footprint

Abbott Laboratories reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 930 Kt (+30/+3.3% y-o-y). At the sime time, carbon intensity was down at 26 t (-4.2 /-13.9% y-o-y).

No public disclosure of Scope 3 emissions has been found for Abbott Laboratories at the moment.

The company is committed to reducing Scope 1 + 2 by 30% by 2030 from a base year 2018, which translates into the estimated reduction of -27 Kt per annum over the period of FY2022 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...